» Articles » PMID: 26131763

Folic Acid Supplements and Colorectal Cancer Risk: Meta-analysis of Randomized Controlled Trials

Overview
Journal Sci Rep
Specialty Science
Date 2015 Jul 2
PMID 26131763
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous studies have investigated the effects of folic acid supplementation on colorectal cancer risk, but conflicting results were reported. We herein performed a meta-analysis based on relevant studies to reach a more definitive conclusion. The PubMed and Embase databases were searched for quality randomized controlled trials (RCTs) published before October 2014. Eight articles met the inclusion criteria and were subsequently analyzed. The results suggested that folic acid treatment was not associated with colorectal cancer risk in the total population (relative risk [RR] = 1.00, 95% confidence interval [CI] = 0.82-1.22, P = 0.974). Moreover, no statistical effect was identified in further subgroup analyses stratified by ethnicity, gender, body mass index (BMI) and potential confounding factors. No significant heterogeneity or publication bias was observed. In conclusion, our meta-analysis demonstrated that folic acid supplementation had no effect on colorectal cancer risk. However, this finding must be validated by further large studies.

Citing Articles

Biological, dietetic and pharmacological properties of vitamin B.

Siatka T, Matus M, Moravcova M, Harcarova P, Lomozova Z, Matousova K NPJ Sci Food. 2025; 9(1):30.

PMID: 40075081 PMC: 11904035. DOI: 10.1038/s41538-025-00396-w.


Chemopreventive strategies for sporadic colorectal cancer: a narrative review.

Monson S, Chen P, Gangi A, Waters K, Billet S, Hendifar A Transl Gastroenterol Hepatol. 2025; 10:11.

PMID: 39944579 PMC: 11811562. DOI: 10.21037/tgh-24-97.


The association between dietary folate intake and risk of colorectal cancer incidence: A systematic review and dose‒response meta-analysis of cohort studies.

Khalighi Sikaroudi M, Soltani S, Kolahdouz-Mohammadi R, Imanifard R, Abdollahi S, Shahinfar H Heliyon. 2024; 10(13):e33564.

PMID: 39071590 PMC: 11279277. DOI: 10.1016/j.heliyon.2024.e33564.


Genome-wide interaction analysis of folate for colorectal cancer risk.

Bouras E, Kim A, Lin Y, Morrison J, Du M, Albanes D Am J Clin Nutr. 2023; 118(5):881-891.

PMID: 37640106 PMC: 10636229. DOI: 10.1016/j.ajcnut.2023.08.010.


Colorectal Cancer Chemoprevention: A Dream Coming True?.

Lepore Signorile M, Grossi V, Fasano C, Simone C Int J Mol Sci. 2023; 24(8).

PMID: 37108756 PMC: 10140862. DOI: 10.3390/ijms24087597.


References
1.
Moher D, Pham B, Jones A, Cook D, Jadad A, Moher M . Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet. 1998; 352(9128):609-13. DOI: 10.1016/S0140-6736(98)01085-X. View

2.
Reynolds E . The neurology of folic acid deficiency. Handb Clin Neurol. 2013; 120:927-43. DOI: 10.1016/B978-0-7020-4087-0.00061-9. View

3.
Choi S, Mason J . Folate and carcinogenesis: an integrated scheme. J Nutr. 2000; 130(2):129-32. DOI: 10.1093/jn/130.2.129. View

4.
Kennedy D, Stern S, Moretti M, Matok I, Sarkar M, Nickel C . Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2010; 35(1):2-10. DOI: 10.1016/j.canep.2010.11.004. View

5.
Gao Q, Chen H, Chen Y, Wang Y, Wang Z, Tang J . Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial. Cancer Prev Res (Phila). 2013; 6(7):744-52. DOI: 10.1158/1940-6207.CAPR-13-0013. View